Introduction: COVID-19 vaccines have been developed to compact the current SARS-CoV-2 pandemic and have been administered to people all over the world. These vaccines have been quite effective in reducing the possibility of severe illness, hospitalization and death. However, the recent emergence of Variants of Concern specifically the delta variant, B.1.617.2, had resulted in additional waves of the pandemic. Methods: We aim to review the literature to understand the transmission and disease severity, and determine the efficacy of the current COVID-19 vaccines. We searched Pubmed, Scopus, and Embase till August 4th 2021, and used the search terms “delta variant”, “vaccinations”,” breakthrough infections”, and “neutralizing antibody”. For th...
Vaccination and disease The United Kingdom has high rates of vaccination for ...
As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible varia...
The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and D...
Introduction: The coronavirus disease 2019 (COVID-19) pandemic continues to inflict significant morb...
Objectives: The highly transmissible COVID-19 Delta variant (DV) has contributed to a surge in cases...
PT-COVID-19 Group: Ausenda Machado, Ana Paula Rodrigues, Carlos Matias Dias, Rita Ferreira, Joana Is...
The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and D...
The SARS-CoV-2 pandemic has impacted public health systems all over the world. The Delta variant see...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant (B.1.617.2) was the p...
The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and D...
Abstract Background From January to May 2021 the alpha variant (B.1....
International audienceThe SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India1,2,3,4,...
Efforts to mitigate the COVID-19 pandemic are underway, andvaccination is imposing selection pressur...
Abstract Background This study aims to identify the causative strain of SARS-CoV-2 in a cluster of v...
The Delta variant (Phylogenetic Assignment of Named Global Outbreak (Pango) lineage designation B.1....
Vaccination and disease The United Kingdom has high rates of vaccination for ...
As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible varia...
The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and D...
Introduction: The coronavirus disease 2019 (COVID-19) pandemic continues to inflict significant morb...
Objectives: The highly transmissible COVID-19 Delta variant (DV) has contributed to a surge in cases...
PT-COVID-19 Group: Ausenda Machado, Ana Paula Rodrigues, Carlos Matias Dias, Rita Ferreira, Joana Is...
The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and D...
The SARS-CoV-2 pandemic has impacted public health systems all over the world. The Delta variant see...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant (B.1.617.2) was the p...
The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and D...
Abstract Background From January to May 2021 the alpha variant (B.1....
International audienceThe SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India1,2,3,4,...
Efforts to mitigate the COVID-19 pandemic are underway, andvaccination is imposing selection pressur...
Abstract Background This study aims to identify the causative strain of SARS-CoV-2 in a cluster of v...
The Delta variant (Phylogenetic Assignment of Named Global Outbreak (Pango) lineage designation B.1....
Vaccination and disease The United Kingdom has high rates of vaccination for ...
As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible varia...
The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and D...